SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 6 — Preventive Visit — David Hume

PatientDavid Hume
Date of birth1962-05-07
IdentifiersMRN HR-EN012-SYN; SSN (made up) 000-12-3049
Document date2026-10-28
AuthorFiona Gallacher, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Adult preventive visit; no new complaints. [S]

History of Present Illness

Mr. Hume returns for the preventive visit that was postponed during chemotherapy. He finished his fourth and last cycle of adjuvant CAPOX three and a half weeks ago and was seen nine days ago to begin survivorship surveillance. His September cold cleared within ten days. The fingertip numbness from oxaliplatin is unchanged and does not affect buttoning or writing. His energy is returning; he walks 30 minutes most days and writes every morning. He has regained a little weight. He completed the health risk assessment before the visit. [S]

ElementDetail
VisitAdult preventive visit, age 64
Recent treatmentAdjuvant CAPOX completed three and a half weeks ago
Active conditionsResected stage IIIB colon cancer under surveillance; grade 1 oxaliplatin neuropathy; liver hemangioma
MedicinesNone regularly since chemotherapy ended
Functional statusIndependent; walking 30 minutes most days

Health risk assessment. Completed by the patient before the visit and reviewed during the visit. [S]

DomainFinding
Self-rated healthGood, and improving since chemotherapy ended
PsychosocialLarge circle of friends; weekly suppers have resumed; no loneliness; no financial strain
BehavioralNever smoker; red wine four or more evenings a week, one to two glasses, never six or more; diet rich in red meat and pastry; walks 30 minutes most days
Activities of daily livingIndependent in all
Instrumental activities of daily livingManages his own medicines, money, correspondence, and travel
Home safetySmoke detectors working; uses a seat belt
Hearing and visionReading glasses; last eye examination more than two years ago; no hearing concern
SleepAbout seven hours a night

Review of Systems

SystemResultFinding
ConstitutionalNegativeEnergy improving; weight up 0.4 kg in nine days; no fever or night sweats
EyesNegativeNo change in vision with reading glasses
Ears, nose, mouth, and throatNegativeCold resolved; no mouth sores
CardiovascularNegativeNo chest pain, palpitations, or ankle swelling
RespiratoryNegativeNo cough or breathlessness
GastrointestinalNegativeOne or two formed stools a day; no blood, pain, or urgency
GenitourinaryNegativeNo urinary symptoms; mild nocturia once a night
MusculoskeletalNegativeNo joint pain
IntegumentaryNegativePalms and soles normal; no new skin lesions
NeurologicalPositiveStable fingertip and toe-tip numbness; no weakness, imbalance, or falls
PsychiatricNegativeMood good; PHQ-2 score 0
HematologicNegativeNo easy bruising or bleeding

12 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Ferric carboxymaltose 750 mg intravenous infusion, two doses one week apart750 mg IV once a week for two dosesIntravenous route2026-06-01 to 2026-06-08completedS
Capecitabine 500 mg oral tablet, four tablets (2000 mg, 1000 mg/m²) by mouth twice daily on days 1 to 14 of each 21-day cycle, four cyclesFour tablets twice daily on days 1 to 14 of each 21-day cycleOral route2026-07-20 to 2026-10-04completedS
Oxaliplatin 130 mg/m² (260 mg) intravenous infusion on day 1 of each 21-day cycle, four cycles260 mg IV on day 1 every 21 daysIntravenous route2026-07-20 to 2026-09-21completedS
Ondansetron 8 mg oral tablet, one tablet by mouth every 8 hours as needed for nausea during chemotherapyOne tablet every 8 hours as needed for nauseaOral route2026-07-20 to 2026-10-04completedS
Loperamide 2 mg oral capsule, two capsules after the first loose stool, then one after each loose stool, no more than eight a dayAs needed for diarrhea on capecitabineOral route2026-07-20 to 2026-10-04completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-10-28Body height178cmS
2026-10-28Body weight81.4kgS
2026-10-28Body mass index (BMI) [Ratio]25.7kg/m2S
2026-10-28Systolic blood pressure122mm[Hg]S
2026-10-28Diastolic blood pressure74mm[Hg]S
2026-10-28Heart rate72/minS
2026-10-28Respiratory rate14/minS
2026-10-28Body temperature36.6CelS
2026-10-28Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-10-28Cholesterol [Mass/volume] in Serum or Plasma196mg/dL<=199 mg/dLNormalS
2026-10-28Cholesterol in HDL [Mass/volume] in Serum or Plasma52mg/dL>=40 mg/dLNormalS
2026-10-28Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation118mg/dL<=99 mg/dLHighS
2026-10-28Hemoglobin A1c/Hemoglobin.total in Blood5.5%<=5.6%NormalS
2026-10-28Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S
2026-10-28Total score [AUDIT-C]4{score}S

Physical Exam

Vital signs recorded on 2026-10-28; see the Vital Signs section. [S]

SystemFinding
ConstitutionalWell-appearing; BMI 25.7
EyesPupils equal and reactive; conjunctivae pink
Ears, nose, and throatNormal; no oral lesions
NeckNo thyroid enlargement or nodes; no carotid bruits
CardiovascularRegular rhythm; no murmur; no edema
RespiratoryClear
AbdomenHealed laparoscopic scars; soft, no masses, no liver enlargement
Lymph nodesNo cervical, axillary, or inguinal nodes
NeurologicalReduced light touch at the fingertips and toe tips; vibration slightly reduced at the toes; strength, reflexes, and gait normal
SkinA few seborrheic keratoses; no suspicious lesions
PsychiatricCheerful, engaged, and good-humoured

Problems

ProblemClinical statusVerificationCodeProvenance
Adenocarcinoma of the sigmoid colon, suspected at presentation and confirmed by colonoscopic biopsy; synthetic modern diagnosis linked to the documented 1775 bowel disorder and its retrospective interpretation as colon canceractiveconfirmed C18.7S — Synthetic diagnosis confirmed by biopsy and resection in the modern episode; the historical diagnosis remains a retrospective interpretation (R).
Iron deficiency anemia from chronic blood loss from the colon tumoractiveconfirmed D50.0S — Synthetic finding echoing the documented 'hemorrhage in the upper part of the intestines'; no blood count from his lifetime exists.
Hemangioma of the liver, 9 mm, segment VI; incidental finding characterized by MRI, not a metastasisactiveconfirmed D18.03S — Synthetic incidental finding; it addresses, and does not confirm, the unverified suggestion of liver spread.
Acute viral upper respiratory infection during adjuvant chemotherapy, without fever or neutropenia; resolvedresolvedconfirmed J06.9S — Synthetic intercurrent illness at an unscheduled visit; it does not echo a documented illness.
Oxaliplatin-induced sensory peripheral neuropathy, grade 1, fingertips and toe tips, without functional impairmentactiveconfirmed G62.0S — Synthetic expected toxicity of adjuvant oxaliplatin.

Assessment and Plan

Personalized prevention plan. A written copy was given to the patient. [S]

ServiceStatusDetail
Influenza vaccine, 2026-2027Completed todayInactivated vaccine given today, three weeks after chemotherapy ended
Pneumococcal vaccineCompleted todayPCV20 given today; recommended for adults 50 and older; no further doses needed
COVID-19 vaccine, 2026-2027DueRecommended; he will get it at his pharmacy
Recombinant zoster vaccineDueTwo-dose series recommended at 50 and older; he chose to start it at his January visit
RSV vaccineDueDiscussed because of his recent chemotherapy; he will decide at the pharmacy visit
Tetanus boosterUp to dateTdap seven and a half years ago; next due in about two and a half years
Hepatitis B vaccineNot indicatedAged 60 or older without risk factors; offered and not wanted
Colorectal cancer screeningNot indicatedReplaced by cancer surveillance: colonoscopy one year after resection, in June
Prostate cancer screeningDeclinedShared decision-making about the small benefit and the risks of overdiagnosis; he chose not to have PSA testing
Hepatitis C and HIV screeningOrderedOne-time screening; no prior result on record; added to the next blood draw
Lung cancer and abdominal aortic aneurysm screeningNot indicatedNever smoker
Cholesterol screening and statin decisionCompleted todayLDL 118 mg/dL; 10-year risk about 10 percent; diet and activity first by shared decision
Diabetes screeningCompleted todayHbA1c 5.5% (BMI 25.7)
Blood pressure screeningCompleted today122/74 mmHg
Depression screeningCompleted todayPHQ-2 score 0
Unhealthy alcohol use screeningCompleted todayAUDIT-C 4, positive; brief counseling given
Physical activity and diet counselingCompleted todayGoal of 150 minutes of walking a week and less red and processed meat
Eye examinationDueMore than two years since his last examination; he will book with his optometrist

Immunizations given today: Influenza vaccine, 2026-2027 season; Pneumococcal conjugate vaccine PCV20 [S]

Guideline basis: Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); USPSTF A and B Recommendations (2026); Adult Immunization Schedule by Age, United States, 2025 (2025)

Follow-up: Hepatitis C and HIV tests with the next blood draw. CT in December. Surveillance visit with CEA and the first zoster vaccine dose in January. Next preventive visit in one year. [S]

Advance Care Planning

Voluntary advance care planning discussion of about 20 minutes, with his consent, prompted by his cancer diagnosis. He has named a health care agent and completed a written health care directive, now scanned into the chart. If the cancer recurs, he wants a frank account of the options and their expected benefit, and he would accept surgery or chemotherapy that offered a real chance of cure or of more good time. He would not want resuscitation or prolonged life support if recovery to independent life and work were not expected, and he would want comfort-focused care at home at the end of life. [S]